1. Articles from manchestertimes.com

  2. 1-4 of 4
    1. INHIBITOR Therapeutics Appoints Dr. Debra Peattie to its Board of Directors

      INHIBITOR Therapeutics Appoints Dr. Debra Peattie to its Board of Directors

      TAMPA, Fla., Oct. 31, 2019 /PRNewswire/ -- INHIBITOR Therapeutics, Inc. (OTCQB: INTI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders, today announced that Debra Peattie, PhD, MBA has been appointed as an independent member of its Board of Directors...

      Read Full Article
    1-4 of 4
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content